Basic information Application Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyrazines >  2,5-Dichloropyrazine

2,5-Dichloropyrazine

Basic information Application Safety Supplier Related

2,5-Dichloropyrazine Basic information

Product Name:
2,5-Dichloropyrazine
Synonyms:
  • 2,5-DICHLOROPYRAZINE
  • 2,5-Dichloro-1,4-diazine
  • NSC 349788
  • Pyrazine, 2,5-dichloro-
  • 2,5-Dichloropyrazine ISO 9001:2015 REACH
CAS:
19745-07-4
MF:
C4H2Cl2N2
MW:
148.98
Product Categories:
  • Pyrazine
  • Building Blocks
  • Pyrazines
  • Piperazine series
Mol File:
19745-07-4.mol
More
Less

2,5-Dichloropyrazine Chemical Properties

Melting point:
0 °C (approx)
Boiling point:
184.4±35.0 °C(Predicted)
Density 
1.493±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
form 
liquid
pka
-4.23±0.10(Predicted)
color 
Colourless
InChI
InChI=1S/C4H2Cl2N2/c5-3-1-7-4(6)2-8-3/h1-2H
InChIKey
JVSDZAGCHKCSGR-UHFFFAOYSA-N
SMILES
C1(Cl)=NC=C(Cl)N=C1
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22-41
Safety Statements 
26-39
HS Code 
29339900
More
Less

2,5-Dichloropyrazine Usage And Synthesis

Application

2,5-Dichloropyrazine is a pharmaceutical intermediate that can be obtained by first chlorinating pyrazin-2-amine to obtain 5-chloropyrazin-2-amine, and then by diazotization to obtain 2,5-dichloropyrazine.

Chemical Properties

Colorless liquid

Synthesis

33332-29-5

19745-07-4

Step 2: Synthesis of 2,5-dichloropyrazine To a stirred solution of 5-chloropyrazin-2-amine (1 g, 7.751 mmol) in concentrated hydrochloric acid (10 mL), an aqueous solution of sodium nitrite (1.1 g, 15.89 mmol) was slowly added at -10 °C, and the addition process lasted for 1 hour. After addition, the reaction mixture was stirred at 0 °C for 1 h, and then brought to room temperature and continued stirring for 2 h. The reaction was carried out by thin layer chromatography (TLC). The reaction process was monitored by thin layer chromatography (TLC). Upon completion of the reaction, the reaction mixture was neutralized with 50% sodium hydroxide (NaOH) solution and subsequently extracted with dichloromethane (DCM). The organic layers were combined, dried with anhydrous sodium sulfate and concentrated under reduced pressure to remove the solvent. The crude product was purified by column chromatography on silica gel (100-200 mesh) to afford 2,5-dichloropyrazine (0.59 g, 15% yield) as a colorless oil using hexane solution containing 2% ethyl acetate as eluent. Mass spectrum (MS): 184.1 [M-1].

References

[1] Patent: US2017/291910, 2017, A1. Location in patent: Paragraph 0565-0567
[2] Patent: WO2008/85316, 2008, A1. Location in patent: Page/Page column 53-54
[3] Patent: WO2005/97778, 2005, A1. Location in patent: Page/Page column 15
[4] Patent: WO2004/56369, 2004, A1. Location in patent: Page/Page column 24
[5] Patent: WO2005/123723, 2005, A1. Location in patent: Page/Page column 11-12

2,5-DichloropyrazineSupplier

Suzhou Xinkai Bio-Medical Technology Co., Ltd. Gold
Tel
0512-67213637 13952409868
Email
peter19zhang@163.com
Suzhou Nuobeike Biological Technology Co., Ltd. Gold
Tel
13962527677
Email
1551481742@qq.com
Kohn & Shawn Pharmatech Co.,Ltd Gold
Tel
0931-4190454 13893344397
Email
sales@kyxpharma.com
Tongchuang Pharma(Suzhou). Co., Ltd. Gold
Tel
0512-63263366 18912765016
Email
tongtf110@sina.com
Suzhou Guide Fine Material Co.Ltd. Gold
Tel
0512-66627360 13914021065
Email
706938434@qq.com